• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during pregnancy and breastfeeding is a difficult decision for women suffering from the condition. Little data exists about how long-term exposure to these drugs may affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications need to balance the benefits of taking them against the potential risks to the foetus. The doctors don't have the information to make unambiguous recommendations but they can provide information on risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. Researchers used a vast, population-based case-control study to assess the risk of major structural birth defects in babies born to mothers who took stimulants during early pregnancy, and those who did not. Pediatric cardiologists and clinical geneticists examined the cases to ensure an accurate classification of the cases and to reduce the chance of bias.

The research conducted by the researchers was not without its limitations. The researchers were not able to, in the first place to differentiate the effects caused by the medication from the disorder. That limitation makes it difficult to determine whether the limited associations observed in the exposed groups are due to medication use or confounding by comorbidities. Additionally the researchers did not look at the long-term outcomes of offspring.

The study revealed that infants whose mother took ADHD medication during pregnancy had a slightly higher chance of being admitted to the neonatal care unit (NICU), compared to those whose mothers did not use any medication during pregnancy, or had discontinued taking their medication prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the increased risk of admission did not appear to be influenced by the stimulant medications were used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having to have caesarean sections or a baby that scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the higher benefit to both mother and child from continued treatment for the woman's condition. Physicians should discuss the issue with their patients and, when possible, assist them in developing strategies to improve coping skills which can reduce the negative impact of her condition on her daily functioning and relationships.

best medication for adhd and anxiety Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the question of whether to keep or discontinue treatment during pregnancy is a question that more and more physicians have to face. Most of the time, these decisions are made without clear and authoritative evidence either way, so physicians must weigh what they know, the experiences of other doctors, and what the research suggests on the subject and their own judgments for each patient.

The issue of possible risks to the infant can be difficult to determine. The research that has been conducted on this topic is based on observations rather than controlled studies and a lot of the results are contradictory. In addition, most studies limit their analysis to live births, which may undervalue the serious teratogenic effects that can result in abortion or termination of the pregnancy. The study discussed in the journal club addresses these limitations, by examining both data on live and deceased births.

Conclusion Some studies have revealed a positive correlation between ADHD medications and certain birth defects however, other studies haven't shown such a relationship. Most studies show a neutral, or even slightly negative, effect. As a result an accurate risk-benefit analysis is required in every instance.

For a lot of women with ADHD who suffer from ADHD, the decision to stop medication is difficult if not impossible. In fact, in a recent article in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation and family conflict for these patients. A decrease in medication could also affect the ability to drive safely and perform work-related tasks, which are vital aspects of normal life for those suffering from ADHD.

She recommends women who are unsure about whether or not to discontinue medication due to their pregnancy should consider informing family members, friends and colleagues about the condition, its effects on daily life, and the advantages of staying on the current treatment plan. It will also help a woman feel more confident in her decision. It is important to remember that certain medications are able to pass through the placenta, so if the patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug can be transferred to the infant.

Risk of Birth Defects

As the use and misuse of adhd uk medication drugs to treat symptoms of attention deficit disorder hyperactivity disorder (adhd medication names list), increases, so does concern about the potential adverse effects of the drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. Researchers used two massive datasets to analyze over 4.3 million pregnant women and determine whether stimulant medications caused birth defects. While the overall risk remains low, the researchers found that exposure in the first trimester to ADHD medicines was associated with an increased risk of certain heart defects, such as ventriculo-septal defect (VSD).

The authors of the study found no connection between early use of medication and other congenital abnormalities, such as facial clefting or club foot. The results are in the same vein as previous studies that have shown an insignificant, but small increase in the number of cardiac malformations among women who began taking ADHD medication before the time of pregnancy. The risk grew in the later part of pregnancy, as many women decide to stop taking their medication.

Women who took ADHD medications during the first trimester of pregnancy were also more likely to undergo caesarean sections, a low Apgar score after delivery and a baby who required help breathing at birth. The researchers of the study could not remove bias in selection since they limited the study to women with no other medical conditions that could have contributed to the findings.

Researchers hope their research will inform physicians when they encounter pregnant women. They advise that while discussing the risks and benefits is crucial however, the decision to stop or keep medication should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also warn that even though stopping the medication is an option, it isn't an option that is recommended due to the high rate of depression and other mental health problems in women who are pregnant or post-partum. Furthermore, research suggests that women who choose to stop taking their medications are more likely to experience a difficult time adjusting to life without them following the birth of their baby.

Nursing

It can be a challenge becoming a mother. Women with ADHD are often faced with a number of difficulties when they must manage their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to new routines. Therefore, many women elect to continue taking their ADHD medication throughout the pregnancy.

The risk to breastfeeding infant is not too high since the majority of stimulant medication is absorbed through breast milk in low amounts. However, the amount of medication exposure to the newborn may differ based on dosage, frequency it is administered, and the time of the day the medication is administered. Additionally, individual medications enter the body of the baby differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn infant is not well known.

Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the absence of research. This is a difficult choice for the patient, who must balance the benefit of continuing her medication against the possible risks to the foetus. Until more information is available, GPs should ask all pregnant patients about their history of ADHD and whether they are taking or planning to take medication during the perinatal period.

Numerous studies have proven that women can continue to take their Adhd Sleep medication (zenwriting.Net) medication without risk during pregnancy and breast-feeding. In response, an increasing number of patients are choosing to do this. They have discovered, in consultation with their doctor, that the benefits of continuing their current medication far outweigh any possible risks.

Women with adhd medication names list who plan to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should review their medications with their physician and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation should also be offered to help women with ADHD be aware of their symptoms and underlying disorder, learn about available treatment options and reinforce existing strategies for coping. This should be a multidisciplinary process with the GPs, obstetricians, and psychiatry. The pregnancy counselling should consist of the discussion of a plan for management for both the mother as well as the child, monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.